A new three-pronged blood test can highlight people with a nearly tripled risk for heart attack, Wake Forest University ...

New diagnostic kits aim to revolutionize early screening of the disease, potentially allowing patients to receive ...

Is Galleri the future of cancer treatment? It's not that simple. The new research from the company, while promising, isn't ...

Lucent Diagnostics, a brand of Quanterix (QTRX) Corporation, has introduced LucentAD Complete, a new multi-marker blood test designed to help detect Alzheimer’s Disease (AD) in a broader range of ...

BILLERICA, Mass.--(BUSINESS WIRE)--Lucent Diagnostics, a brand of Quanterix Corporation (NASDAQ: QTRX), has introduced LucentAD Complete, a new multi-marker blood test designed to help detect ...

A 96% accurate blood test for ME/CFS could transform diagnosis and pave the way for future long COVID detection. Researchers from the University of East Anglia and Oxford Biodynamics have created a ...

Share on Pinterest Blood tests may help detect some neurodegenerative diseases in the future. Patricio Nahuelhual/Getty Images Researchers have discovered a blood marker they say can help in ...

A new study looking at deaths from cancer, cardiovascular disease and all causes suggests that an inflammatory marker detected in blood tests in middle-aged adults can better predict the risk of death ...

Please provide your email address to receive an email when new articles are posted on . Biomarker combinations improved detection of pancreatic cancer in a double-blind trial. A phase 3 investigation ...

Alzheimer’s disease is hard to diagnose. But proteins in the blood might provide clarity. A series of recent findings, presented at the annual Alzheimer’s Association International Conference in ...

Indian researchers identify blood markers for early diabetes and kidney risk, enabling personalized treatment and timely ...

A new three-pronged blood test can show which people have a nearly tripled risk of heart attack. The test looks for two ...